Whanin Pharm Co Ltd banner
W

Whanin Pharm Co Ltd
KRX:016580

Watchlist Manager
Whanin Pharm Co Ltd
KRX:016580
Watchlist
Price: 10 690 KRW -1.29% Market Closed
Market Cap: ₩163.2B

Balance Sheet

Balance Sheet Decomposition
Whanin Pharm Co Ltd

Balance Sheet
Whanin Pharm Co Ltd

Rotate your device to view
Balance Sheet
Currency: KRW
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
12 087
1 622
17 109
18 524
8 453
29 315
20 296
17 696
31 213
18 976
33 991
50 823
45 020
37 046
48 609
57 770
39 928
38 513
17 982
36 074
64 056
36 776
45 366
43 147
Cash
0
0
0
0
0
0
0
0
0
0
0
117
229
15
18
0
0
0
0
0
0
0
0
0
Cash Equivalents
12 087
1 622
17 109
18 524
8 453
29 315
20 296
17 696
31 213
18 976
33 991
50 706
44 791
37 031
48 591
57 770
39 928
38 513
17 982
36 074
64 056
36 776
45 366
43 147
Short-Term Investments
3 086
17 074
3 815
5
12 510
3 000
21 253
14 622
11 815
36 093
21 537
18 781
29 575
37 668
19 559
22 710
40 598
54 706
93 809
80 882
81 987
50 516
32 700
8 915
Total Receivables
21 403
24 591
28 159
32 286
34 191
32 295
35 950
40 677
40 995
45 334
51 399
47 336
48 492
63 260
67 617
64 373
69 831
68 565
64 555
64 106
63 120
72 326
78 947
75 709
Accounts Receivables
21 031
23 895
27 274
31 283
33 039
31 457
35 164
39 491
39 770
44 076
49 947
45 644
46 709
60 356
64 829
62 464
67 586
66 048
63 766
63 350
62 301
68 659
75 101
71 176
Other Receivables
372
696
885
1 003
1 152
838
786
1 186
1 225
1 258
1 452
1 692
1 783
2 904
2 788
1 909
2 245
2 517
789
756
819
3 667
3 846
4 532
Inventory
4 856
5 221
5 592
8 146
14 694
7 175
7 664
12 241
12 172
13 952
12 311
14 438
15 980
19 047
20 499
18 524
21 345
25 899
28 218
32 764
32 745
37 060
54 058
72 411
Other Current Assets
202
52
244
716
265
618
72
1 698
669
402
104
93
4 458
91
115
113
111
150
413
529
504
744
1 031
1 115
Total Current Assets
41 634
48 560
54 919
59 678
70 113
72 404
85 235
86 933
96 863
114 757
119 342
131 471
143 525
157 111
156 399
163 491
171 814
187 833
204 977
214 355
242 412
197 422
212 101
201 297
PP&E Net
13 369
12 742
13 766
16 639
17 261
19 637
18 286
17 916
18 104
33 063
34 667
38 078
37 712
51 960
52 408
57 689
39 815
39 279
39 697
45 822
46 869
109 854
131 211
149 218
PP&E Gross
13 369
12 742
13 766
16 639
17 261
19 637
18 286
17 916
18 104
0
0
0
0
0
52 408
57 689
39 815
39 279
39 697
45 822
46 869
109 854
131 211
149 218
Accumulated Depreciation
6 210
7 681
8 934
9 330
11 685
13 017
14 758
16 754
18 505
0
0
0
0
0
21 416
22 624
21 918
23 032
24 288
25 716
28 227
30 722
34 180
40 969
Intangible Assets
460
940
1 006
917
957
931
1 429
1 423
2 790
4 272
4 882
4 670
3 790
1 786
2 203
1 237
1 763
2 378
3 115
2 988
2 969
3 176
5 382
7 160
Note Receivable
217
272
252
245
198
192
206
204
242
255
1 246
1 270
1 374
332
281
292
151
0
25
19
30
20
38
19
Long-Term Investments
2 006
872
193
219
4 920
4 429
69
148
39
13
5 013
5 000
5 769
5 731
22 869
19 321
60 431
58 194
56 255
65 493
60 248
57 463
52 232
65 091
Other Long-Term Assets
767
792
1 003
901
993
912
1 012
956
908
910
960
939
931
924
890
1 411
865
3
816
883
660
1 440
262
1 920
Total Assets
58 453
N/A
64 177
+10%
71 138
+11%
78 600
+10%
94 442
+20%
98 506
+4%
106 237
+8%
107 580
+1%
118 946
+11%
153 270
+29%
166 110
+8%
181 428
+9%
193 101
+6%
217 845
+13%
235 050
+8%
243 441
+4%
274 838
+13%
287 687
+5%
304 885
+6%
329 560
+8%
353 189
+7%
369 375
+5%
401 227
+9%
424 706
+6%
Liabilities
Accounts Payable
1 150
926
879
1 113
1 931
1 808
1 972
2 873
2 560
3 263
3 254
4 319
5 641
9 310
12 903
9 033
11 505
10 475
9 177
8 865
9 422
11 966
18 071
22 456
Accrued Liabilities
790
1 110
3 849
4 950
1 019
1 542
1 604
1 706
1 757
2 445
2 932
3 827
2 835
2 867
3 290
2 672
3 065
3 125
4 083
4 151
6 713
4 280
4 920
4 986
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
60
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
427
547
416
186
325
278
Other Current Liabilities
6 893
4 131
3 492
4 505
5 916
3 346
5 936
4 118
4 848
5 215
4 989
5 324
6 036
12 327
7 541
8 398
13 416
10 057
11 057
13 163
14 349
15 318
16 711
14 656
Total Current Liabilities
8 894
6 167
8 220
10 568
8 866
6 696
9 512
8 697
9 164
10 923
11 175
13 470
14 513
24 503
23 734
20 102
27 987
23 656
24 743
26 725
30 900
31 750
40 028
42 376
Long-Term Debt
0
0
0
0
119
81
40
0
0
0
0
0
0
0
0
0
0
0
1 134
1 643
1 305
64
307
136
Deferred Income Tax
1 568
1 471
769
829
1 376
1 368
797
271
334
4 845
4 177
4 821
4 922
4 262
4 076
2 908
2 456
1 808
1 228
2 011
1 098
368
0
0
Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
684
487
286
417
0
0
Other Liabilities
0
663
723
991
1 630
1 470
858
770
1 011
521
903
607
456
558
647
302
1 312
2 639
3 318
2 578
2 660
3 264
2 684
6 192
Total Liabilities
10 462
N/A
8 301
-21%
9 712
+17%
12 388
+28%
11 991
-3%
9 615
-20%
11 207
+17%
9 737
-13%
10 510
+8%
16 289
+55%
16 255
0%
18 899
+16%
19 890
+5%
29 324
+47%
28 456
-3%
23 312
-18%
31 755
+36%
28 103
-12%
31 108
+11%
33 445
+8%
36 249
+8%
35 863
-1%
43 019
+20%
48 704
+13%
Equity
Common Stock
9 700
9 700
9 700
9 700
9 700
9 700
9 700
9 700
9 700
9 700
9 700
9 700
9 700
9 700
9 700
9 700
9 700
9 700
9 700
9 700
9 700
9 700
9 700
9 700
Retained Earnings
27 062
35 713
41 733
50 333
60 804
67 283
68 165
76 984
87 687
118 375
129 345
141 325
152 089
167 077
183 770
196 351
219 706
239 963
254 079
273 163
295 449
314 790
339 984
358 861
Additional Paid In Capital
17 300
17 717
17 494
17 494
21 216
21 216
23 896
23 896
23 896
18 903
21 135
21 135
21 135
21 135
21 135
21 135
21 135
21 135
21 135
21 135
21 135
20 817
21 062
21 062
Unrealized Security Profit/Loss
235
9
0
0
23
16
987
5 018
1 147
0
0
0
0
0
0
0
0
0
0
0
0
0
2 870
0
Treasury Stock
6 305
7 245
7 501
11 316
9 292
9 292
7 718
7 718
11 700
11 700
9 669
9 669
9 669
9 669
9 669
9 669
9 669
9 669
9 669
9 669
9 669
9 669
9 669
9 669
Other Equity
0
0
0
0
0
0
0
0
0
1 703
656
39
44
278
1 658
2 613
2 211
1 545
1 468
1 787
325
2 126
2 870
3 952
Total Equity
47 991
N/A
55 876
+16%
61 426
+10%
66 211
+8%
82 451
+25%
88 891
+8%
95 030
+7%
97 843
+3%
108 436
+11%
136 981
+26%
149 855
+9%
162 530
+8%
173 210
+7%
188 522
+9%
206 594
+10%
220 129
+7%
243 084
+10%
259 584
+7%
273 777
+5%
296 115
+8%
316 939
+7%
333 511
+5%
358 207
+7%
376 002
+5%
Total Liabilities & Equity
58 453
N/A
64 177
+10%
71 138
+11%
78 600
+10%
94 442
+20%
98 506
+4%
106 237
+8%
107 580
+1%
118 946
+11%
153 270
+29%
166 110
+8%
181 428
+9%
193 101
+6%
217 845
+13%
235 050
+8%
243 441
+4%
274 838
+13%
287 687
+5%
304 885
+6%
329 560
+8%
353 189
+7%
369 375
+5%
401 227
+9%
424 706
+6%
Shares Outstanding
Common Shares Outstanding
18
16
16
14
15
15
15
15
15
15
15
15
15
15
15
15
15
15
15
15
15
15
15
15
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett